What does the GAM (IgG, IgA, IgM) immunoglobulins test measure and when should it be ordered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

GAM Immunoglobulins Test

The GAM immunoglobulins test measures serum levels of IgG, IgA, and IgM antibodies and should be ordered as the initial screening test when evaluating patients with recurrent sinopulmonary infections, suspected primary immunodeficiency, or unexplained severe/recurrent infections. 1

What the Test Measures

The GAM test quantifies the three major immunoglobulin isotypes in serum:

  • IgG: The most abundant antibody (comprises ~60% of total immunoglobulin), provides long-term immunity against bacteria and viruses
  • IgA: Protects mucosal surfaces; deficiency found in approximately 9.3% of patients with respiratory tract infections 1
  • IgM: The first antibody produced in immune responses; important for early pathogen recognition

When to Order the Test

Primary Indications:

  • Recurrent sinopulmonary infections (sinusitis, otitis media, pneumonia) with encapsulated bacteria 1

  • Suspected primary immunodeficiency disorders including:

    • Common Variable Immunodeficiency (CVID)
    • Selective IgA Deficiency (SIGAD)
    • Agammaglobulinemia
    • IgG subclass deficiency 1

  • Recurrent viral respiratory or gastrointestinal infections 1

  • Failure to thrive with chronic diarrhea (particularly in infants/children)

  • Autoimmune disease with recurrent infections 1

  • Family history of primary immunodeficiency 1

Secondary Considerations:

  • Evaluation before initiating immunoglobulin replacement therapy 2
  • Monitoring patients on medications that can cause hypogammaglobulinemia (phenytoin, carbamazepine, valproic acid, sulfasalazine) 1
  • Atopic disease with unusually severe or recurrent infections 1

Critical Interpretation Points

The test alone is insufficient for diagnosis:

Measuring total immunoglobulins is frequently inadequate when used in isolation 1. The 2015 practice parameter emphasizes that evaluation of specific antibody responses to both protein and polysaccharide antigens is essential for diagnosing primary immunodeficiencies 1.

Key Pitfalls to Avoid:

  1. Normal GAM levels do NOT rule out antibody deficiency: Patients can have normal total IgG, IgA, and IgM but still have:

    • Selective antibody deficiency (SAD) with impaired vaccine responses 1
    • IgG subclass deficiency (IGGSD) 1
    • Functional antibody defects 2

  2. Age-appropriate reference ranges are critical: Immunoglobulin levels vary significantly by age, particularly in children 3

  3. Single abnormal result requires confirmation: Any abnormal immunoglobulin level should be confirmed with at least one additional measurement at least 1 month apart 1

Algorithmic Approach After GAM Testing

If GAM levels are LOW:

  • IgG, IgA, IgM all low/absent → Consider agammaglobulinemia or severe CVID; measure B cells 1
  • IgG low, IgA/IgM normal or low → Consider CVID, unspecified hypogammaglobulinemia, or secondary causes; check serum total protein/albumin to exclude protein-losing conditions 1
  • IgA absent, IgG/IgM normal → Selective IgA deficiency; measure specific antibody responses 1

If GAM levels are NORMAL but clinical suspicion remains high:

  1. Measure specific antibody responses to protein antigens (tetanus, diphtheria) and polysaccharide antigens (pneumococcal vaccine) 1
  2. Consider IgG subclass testing only if recurrent respiratory infections persist with normal GAM levels 1
  3. Evaluate cellular immunity if opportunistic infections are present 1

Cost-Effectiveness Considerations

Measuring IgG subclasses adds cost and is frequently unnecessary when total immunoglobulins and specific antibodies are measured 1. The guideline explicitly states that IgG subclass measurement is not universally recommended as part of initial evaluation 1.

Treatment Implications

The GAM test results directly guide management decisions:

  • Aggressive antimicrobial therapy and prophylaxis for patients with documented deficiencies and recurrent infections 1
  • Immunoglobulin replacement therapy consideration for severe deficiencies (typically IgG <400 mg/dL with impaired specific antibody responses) 1, 2
  • Monitoring for progression: Some patients with isolated deficiencies can evolve into more severe phenotypes like CVID over time 1

Important caveat: The decision to initiate immunoglobulin replacement should never be based solely on GAM levels but must incorporate clinical severity, specific antibody function testing, and documented infectious complications affecting quality of life 2.

References

1
Guideline

practice parameter for the diagnosis and management of primary immunodeficiency.

Journal of Allergy and Clinical Immunology, 2015

Related Questions

What causes low Immunoglobulin G (IgG) levels?
What is the differential diagnosis for a patient with severe allergies and elevated IgE levels?
What is the appropriate evaluation and differential diagnosis for an isolated IgM elevation accompanied by increased total IgG and IgG subclass 1?
How long do secretory Immunoglobulin A (IgA) levels remain low after antibiotic treatment in a patient with a history of autoimmune disorders or recurrent infections?
What does a low α‑1 globulin level of 0.3 g/dL indicate and how should it be evaluated and managed?
When should methotrexate be initiated for a patient who has not yet received it, and what is the appropriate starting dose, titration schedule, and monitoring plan?
When can methotrexate be safely initiated in a patient who has had recent infections and recent hospitalization?
In congestive heart failure, how long was continuous positive airway pressure administered during the clinical trials?
What should a man do if he experiences sexual side effects from finasteride during the first month of treatment?
How is micafungin administered?
What precautions, drug interactions, and monitoring requirements should be considered for a patient on methotrexate therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.